Your browser doesn't support javascript.
loading
New treatments for multidrug-resistant non-fermenting Gram-negative bacilli Infections
Chumbita, Mariana; Monzo-Gallo, Patricia; Lopera-Mármol, Carlos; Aiello, Tommaso Francesco; Puerta-Alcalde, Pedro; Garcia-Vidal, Carolina.
Afiliación
  • Chumbita, Mariana; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Monzo-Gallo, Patricia; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Lopera-Mármol, Carlos; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Aiello, Tommaso Francesco; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Puerta-Alcalde, Pedro; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
  • Garcia-Vidal, Carolina; University of Barcelona. Hospital Clinic of Barcelona-IDIBAPS. Department of Infectious Diseases. Barcelona. Spain
Rev. esp. quimioter ; 35(Supl. 3): 51-53, Oct. 2022.
Article en En | IBECS | ID: ibc-210749
Biblioteca responsable: ES1.1
Ubicación: ES15.1 - BNCS
ABSTRACT
Ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol belong to a novel generation of antibiotics that correspond with the β-lactam family. It is necessary to having new options in treating infections caused by Gram-negative, non-fermenting multidrug-resistant bacilli due to the significant increase in multidrug resistance in the last decades. Knowing the main characteristics of each drug is key for correct use. (AU)
Asunto(s)

Texto completo: 1 Colección: 06-national / ES Banco de datos: IBECS Asunto principal: Beta-Lactamas / Antibacterianos Límite: Humans Idioma: En Revista: Rev. esp. quimioter Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 06-national / ES Banco de datos: IBECS Asunto principal: Beta-Lactamas / Antibacterianos Límite: Humans Idioma: En Revista: Rev. esp. quimioter Año: 2022 Tipo del documento: Article